Stock listing

NASDAQ:RPRX Repros Therapeutics Stock

Follow Repros Therapeutics into a list and get an email when it puts out news.

Last close · NASDAQ:RPRX

$0.67 USD

Close on Jan 31, 2018 · No longer trades

May 4, 2006 to last close -93.8% · monthly closes, May 4, 2006 – Jan 31, 2018
Lowest – highest close
$0.271 – $28.39 USDSince May 4, 2006 · lowest Aug 22, 2017 · highest Sep 23, 2013

Delisted NASDAQ:RPRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RPRX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Repros Therapeutics on 6ix

Decks
30 decks · latest Sep 11, 2017

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 4, 2026 · Before open+1.8%
Quarter to Jun 30, 2026Aug 5, 2026 · Before open+0.5%
Quarter to Mar 31, 2026May 6, 2026 · Before open+0.6%
Quarter to Dec 31, 2025Feb 11, 2026 · Before open+0.1%
Quarter to Sep 30, 2025Nov 5, 2025 · Before open+6.8%
Quarter to Jun 30, 2025Aug 6, 2025 · Before open−2.1%
Quarter to Mar 31, 2025May 8, 2025 · Before open+1.1%
Quarter to Dec 31, 2024Feb 11, 2025 · Before open+1.7%
Quarter to Sep 30, 2024Nov 6, 2024 · Before open−3.3%
Quarter to Jun 30, 2024Aug 8, 2024 · Before open−4.0%
All 20 quarters
QuarterResultsShare move
Quarter to Mar 31, 2024May 9, 2024 · Before open−0.1%
Quarter to Dec 31, 2023Feb 15, 2024 · Before open+2.5%
Quarter to Sep 30, 2023Nov 8, 2023 · Before open+0.3%
Quarter to Jun 30, 2023Aug 8, 2023 · Before open−0.9%
Quarter to Mar 31, 2023May 9, 2023 · Before open−4.3%
Quarter to Dec 31, 2022Feb 15, 2023 · Before open−0.8%
Quarter to Sep 30, 2022Nov 8, 2022 · Before open+0.8%
Quarter to Jun 30, 2022Aug 4, 2022 · Before open−0.8%
Quarter to Mar 31, 2022May 5, 2022 · Before open−5.6%
Quarter to Dec 31, 2021Feb 15, 2022 · Before open+3.1%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2017)Investor deck16 slidesSep 11, 2017
Investor Presentation (May 2017)Investor deck16 slidesMay 17, 2017
Investor Presentation (May 2017)Investor deck16 slidesMay 2, 2017
Investor Presentation (November 2016)Investor deck37 slidesNov 15, 2016
Investor Presentation (September 2016)Investor deck26 slidesSep 12, 2016
Investor Presentation (August 2016)Investor deck34 slidesAug 18, 2016
Investor Presentation (July 2016)Investor deck40 slidesJul 19, 2016
Investor Presentation (June 2016)Investor deck20 slidesJun 7, 2016
Investor Presentation (November 2015)Investor deck40 slidesNov 17, 2015
Investor Presentation (September 2015)Investor deck26 slidesSep 29, 2015
All 30 decks
DeckKindSlidesDate
Investor Presentation (April 2015)Investor deck21 slidesApr 8, 2015
Investor Presentation (January 2015)Investor deck63 slidesJan 12, 2015
Investor Day (October 2014)Investor day119 slidesOct 31, 2014
Investor Presentation (September 2014)Investor deck35 slidesSep 22, 2014
Investor Presentation (August 2014)Investor deck28 slidesAug 20, 2014
Investor Presentation (May 2014)Investor deck32 slidesMay 13, 2014
Investor Presentation (May 2014)Investor deck36 slidesMay 8, 2014
Investor Presentation (February 2014)Investor deck37 slidesFeb 10, 2014
Investor Presentation (September 2013)Investor deck37 slidesSep 27, 2013
Investor Presentation (July 2013)Investor deck30 slidesJul 9, 2013
Investor Presentation (June 2013)Investor deck24 slidesJun 7, 2013
Investor Presentation (June 2012)Investor deck37 slidesJun 7, 2012
Investor Presentation (December 2011)Investor deck17 slidesDec 1, 2011
Rodman & Renshaw 13th Annual Health Care Conference (September 2011)Conference23 slidesSep 12, 2011
Investor Presentation (February 2010)Investor deck35 slidesFeb 8, 2010
Investor Presentation (February 2008)Investor deck32 slidesFeb 12, 2008
Investor Presentation (January 2008)Investor deck40 slidesJan 10, 2008
Investor Presentation (November 2007)Investor deck46 slidesNov 5, 2007
Zonagen — Investor Presentation (April 2005)Investor deck28 slidesApr 26, 2005
Zonagen — Shareholder Meeting (September 2004)Shareholder meeting17 slidesSep 29, 2004

Open Decks

Cap table

Built by 6ix from Repros Therapeutics’ releases

Common shares
445,265,805
Fully diluted
445,265,805

Fully diluted

LineShares
Common shares445,265,805

Share count over time

CountShares
Nov 22, 2026445,265,805

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Saira Ramasastry
Other companies: Sensei Biotherapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jun 15, 2026); Mirum Pharmaceuticals, Inc. (Director · Since at least Jun 2, 2022); Day One Biopharmaceuticals Inc (Director · Since at least May 26, 2021); Vir Biotechnology, Inc. (Director · Since at least Oct 10, 2019); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Filana Therapeutics, Inc. (Director · Feb 11, 2013 – Dec 13, 2019 · Past); Sangamo Therapeutics, Inc. (Director · Jun 21, 2012 – Feb 25, 2022 · Past)
Director · Mar 25, 2013 – Jan 29, 2018 · Past
Mark P. Lappe
Other companies: Inhibrx Biosciences, Inc. (Founder, Chief Executive Officer · Since at least May 24, 2024); Inhibrx Inc (Chief Executive Officer, Director · Aug 18, 2020 – May 30, 2024 · Past)
Director · Sep 29, 2008 – May 20, 2009 · Past
Patrick Fourteau
Other companies: INSYS Therapeutics Inc (Director · May 2, 2016 – Aug 4, 2017 · Past)
Director · May 12, 2016 – Jan 29, 2018 · Past
Andre MD PhD van AsChief Medical Officer · Jun 6, 2008 – Apr 14, 2009 · Past
Joseph PodolskiPresident and CEO, Director · Jan 3, 2006 – Dec 9, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Repros Therapeutics.